Search clinical trials for: MK0826, /Duration of Treatment : 8 Weeks

Total 410 results

H. Lundbeck A/S

Terminated

Adult Polysomnography Primary Insomnia Cross Over Study (0928-049)(TERMINATED)

Primary Insomnia
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate the Safety and Effectiveness of Ertapenem Versus Ceftriaxone/Metronidazole in the Treatment of Intra-abdominal Infections in Adults (0826-802)

Intra-abdominal Infection
Merck Sharp & Dohme LLC

Completed

Ertapenem Sodium vs. Piperacillin/Tazobactam in the Treatment of Complicated Intra-Abdominal Infections (0826-037)

Complicated Intra-Abdominal Infections
Merck Sharp & Dohme LLC

Completed

Comparative Study of Ertapenem Versus Another Antibiotic in the Treatment of Diabetic Foot Infections in Adults (0826-034)

Foot Infections in Diabetic Patients
Organon and Co

Completed

A Study to Assess the Effect of Montelukast Sodium With Concomitant Administration of Inhaled Budesonide in Asthmatic Patients (0476-075)

Asthma
Institut National de la Santé Et de la Recherche...

Completed

Effects Of An 8-Weeks Mindfulness-based Intervention In Individuals With Subjective Cognitive Decline (SCD-WELL)

Cognitive Dysfunction

France, Germany, Spain, United Kingdom
Universidade Federal do Rio de Janeiro

Completed

Assessment of Thigh Muscle After a Stretching Program

Assessment of Muscle Architecture and Tendon After Chronic Stretching Program

Brazil
Azienda Ospedaliera SS. Antonio e Biagio e Cesare...

Recruiting

Timing to Minimally Invasive Surgery After Neoadjuvant Chemoradiotherapy for Rectal Cancer (TiMiSNAR)

Rectal Cancer

Italy
Organon and Co

Completed

A Study of an Investigational Study Drug for Benign Prostatic Hyperplasia (0906-140)

Benign Prostatic Hyperplasia
Boehringer Ingelheim

Completed

Phase 3 Study of BI 207127 in Combination With Faldaprevir and Ribavirin for Treatment of Patients With Hepatitis C Infection, Including Patients Who Are Not Eligible to Receive Peginterferon: HCVerso2

Hepatitis C, Chronic

United States, Australia, Belgium, Canada, France, Germany, Greece, Italy, New Zealand, Portugal, Spain, United Kingdom
H. Lundbeck A/S

Completed

MK0928 Study in Adult Patients With Primary Insomnia (0928-040)(COMPLETED)

Primary Insomnia
H. Lundbeck A/S

Terminated

Elderly Primary Insomnia Polysomnographic Study (0928-002)(TERMINATED)

Primary Insomnia
Organon and Co

Completed

Effects of Finasteride on Serum Prostate-Specific Antigen (0906-111)

Androgenetic Alopecia
Merck Sharp & Dohme LLC

Completed

To Evaluate the Treatment Effect of an Anti-Infective Agent for Different Kinds of Infections (0826-052)

Pneumonia | Urinary Tract Infection | Infection
Merck Sharp & Dohme LLC

Completed

To Evaluate the Treatment Effect of an Anti-Infective Agent for Complicated Infections (0826-053)

Sepsis
Merck Sharp & Dohme LLC

Completed

Endpoint Validation Study (0524A-015)

Flushing
Organon and Co

Completed

Etoricoxib in the Treatment of Osteoarthritis (MK-0663-007)

Osteoarthritis
Merck Sharp & Dohme LLC

Completed

MK0524A Clinical Efficacy Study (0524A-026)(COMPLETED)

Hypercholesterolemia
Merck Sharp & Dohme LLC

Completed

Ertapenem Study in Pediatric Patients Who Have Urinary Tract Infections, Skin Infections or Community-acquired Pneumonia (0826-036)

Urinary Tract Infections | Soft Tissue Infections | Bacterial Pneumonia
Organon and Co

Completed

A Study Comparing Ezetimibe Plus Simvastatin Versus Simvastatin Alone in Patients at Risk for Heart Disease (0653-023)(COMPLETED)

Coronary Disease
Northwestern University
Shirley Ryan AbilityLab

Terminated

Structured Physical Activity for Sleep Quality and Daytime Sleepiness in Patients With Parkinson's Disease

Parkinson's Disease | Hypersomnia | Poor Quality Sleep

United States
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate the Effect of MK0966 (Rofecoxib) on the Recurrence of Colorectal Adenomas (0966-122)

Colorectal Adenoma
Merck Sharp & Dohme LLC

Completed

Efficacy, Tolerability and Safety Study in Rheumatoid Arthritis (0812-008)

Arthritis, Rheumatoid
Medical College of Wisconsin
Children's Hospital and Health System Foundation, Wisconsin; Santosh Yoga LLC

Terminated

Evaluation of Yoga for the Treatment of Pediatric Headaches

Headache

United States
Merck Sharp & Dohme LLC

Completed

MK0524A Phase IIb Study (0524A-011)(COMPLETED)

Flushing
University of Alberta

Completed

Evaluating the Clinical Efficacy of Resveratrol in Improving Metabolic and Skeletal Muscle Function in Patients With Heart Failure (REV-HF)

Congestive Heart Failure Chronic

Canada
Organon and Co

Completed

Study of an Approved Drug in Patients With Asthma (0476-289)(COMPLETED)

Asthma
Organon and Co

Completed

MK0476 Study in Adult Patients With Allergic Rhinitis (0476-378)

Rhinitis Allergic
Organon and Co

Completed

SINGULAIR (R) as Complementary Therapy to Fixed Association Regimen (0476-363) (STAR)

Asthma
Organon and Co

Completed

Quality of Life in Asthma and Rhinitis Allergic With Singulair (0476-365)

Asthma | Rhinitis Allergic
University of Colorado, Denver

Recruiting

Should Graf IIc Hips be Treated for 12 Weeks

Developmental Dysplasia of Hip

United States
Merck Sharp & Dohme LLC

Terminated

A Study of Rofecoxib in Familial Adenomatous Polyposis (FAP) (0966-205)(TERMINATED)

Adenomatous Polyposis Coli
Michigan State University
The Board of Medicine

Recruiting

Efficacy of the Apollo System for Children With ADHD

Attention Deficit Disorder With Hyperactivity

United States
Stockholm University

Active, not recruiting

The Study of Internet-delivered, Transdiagnostic Treatments for Anxiety and Depression (TRAbee)

Depression | Anxiety Disorders

Sweden
Organon and Co

Completed

HYZAAR vs. Ramipril for Diabetes (0954A-245)(COMPLETED)

Hypertension | Type 2 Diabetes Mellitus
University Hospital, Rouen

Not yet recruiting

Efficacy of Glutamine Supplementation in Patients Suffering From Irritable Bowel Syndrome With Impaired Intestinal Permeability (MISSISIIPI)

Irritable Bowel Syndrome
Virginia Commonwealth University

Completed

Effectiveness of Shortened Time Interval to Postpartum Visit in Improving Postpartum Attendance

Pregnancy Related | Contraception | Contraception Behavior | Contraception Use
Organon and Co

Completed

A Study to Evaluate Ezetimibe in Korean Patients With Primary Hypercholesterolemia (0653-042)

Hypercholerolemia
Organon and Co

Completed

Comparing an Investigational Medication Versus an Approved Medication in Reducing Cholesterol Levels (0653-025)

Hypercholesterolemia
Organon and Co

Completed

Linear Growth Study (0476-097)(COMPLETED)

Asthma
Merck Sharp & Dohme LLC

Completed

Effect of MK0524A on Flushing Caused by Niacin (0524A-056)

Flushing
Laval University

Active, not recruiting

Effects of Blueberry on Gut Microbiota and Metabolic Syndrome

Metabolic Syndrome | Gut Microbiota

Canada
Ove Andersen
Aalborg University; Albertslund Kommune; Gate 21; Chromaviso A/S

Completed

Circadian Adjusted LED Light's Effect in People Living in Elderly Housing (Lightel)

Elderly Housing Residents With Frailty or Dementia

Denmark
Laboratorio Elea Phoenix S.A.
Drugs for Neglected Diseases

Recruiting

Shorter Benznidazole Regimens Compared to the Standard Regimen for Chagas Disease (NuestroBen)

Chagas Disease

Argentina
Organon and Co

Completed

Eze/Simva Switch Study in Diabetics (0653A-807)

Diabetes Mellitus, Type 2
Organon and Co

Terminated

Vytorin Treating Uncontrolled Lipids (VyTUL) Study (0653A-122)

Cardiovascular Diseases | Diabetes Mellitus
Organon and Co

Completed

Study Evaluating the Efficacy and Safety of Simvastatin Alone Compared With Simvastatin Plus Ezetimibe in Type 2 Diabetic Patients (0653-021)(COMPLETED)

Diabetes Mellitus, Type 2
Ipsen

Completed

Efficacy and Tolerability of Lanreotide (Autogel 120 mg) in Patients With Acromegaly

Acromegaly

Italy
University of Ulster
Western Health and Social Care Trust

Suspended

Replenishing and Maintaining Vitamin D Status in Older Adults in Residential Care Facilities in NI

Vitamin D Deficiency

United Kingdom
Organon and Co

Completed

Study to Test a Marketed Drug in the Treatment of Menstrual Migraine (0462-071)

Migraine

3

Subscribe